Advagene Biopharma Co. Ltd.

Develops mucosal adjuvant and mucosal immunotherapy drugs. The portfolio includes nasal spray vaccines for seasonal flu and COVID-19 and immunotherapies for allergy, COVID-19, RSV, and rhinovirus-induced asthma. Source

Keywords: mucosal adjuvant mucosal immunotherapy nasal spray vaccines influenza asthma